Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration
=============================================================================================================================================

* Mark N. Stein
* Jyoti Malhotra
* Rohinton S. Tarapore
* Usha Malhotra
* Ann W. Silk
* Nancy Chan
* Lorna Rodriguez
* Joseph Aisner
* Robert D. Aiken
* Tina Mayer
* Bruce G. Haffty
* Jenna H. Newman
* Salvatore M. Aspromonte
* Praveen K. Bommareddy
* Ricardo Estupinian
* Charles B. Chesson
* Evita T. Sadimin
* Shengguo Li
* Daniel J. Medina
* Tracie Saunders
* Melissa Frankel
* Aparna Kareddula
* Sherrie Damare
* Elayne Wesolowsky
* Christian Gabel
* Wafik S. El-Deiry
* Varun V. Prabhu
* Joshua E. Allen
* Martin Stogniew
* Wolfgang Oster
* Joseph R. Bertino
* Steven K. Libutti
* Janice M. Mehnert
* Andrew Zloza